Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ketan R Hosamani
Observed name:
Ketan R. Hosamani
ORCID:
0009-0002-6078-1171
Observed ORCID:
0009-0002-6078-1171
OpenAlex ID:
A5099420403
An insight into sustainable and green chemistry approaches for the synthesis of quinoline derivatives as anticancer agents
2024
·
B. Kumaraswamy
, K. Hemalatha
, et al.
·
European Journal of Medicinal Chemistry
·
46
Benzothiazole a privileged scaffold for Cutting-Edges anticancer agents: Exploring drug design, structure-activity relationship, and docking studies
2024
·
Aayishamma I
, Gurubasavaraja Swamy Purawarga Matada
, et al.
·
European Journal of Medicinal Chemistry
·
40
Pyrazole, Pyrazoline, and Fused Pyrazole Derivatives: New Horizons in EGFR‐Targeted Anticancer Agents
2024
·
Ketan R Hosamani
, Hemalatha K
, et al.
·
Chemistry & Biodiversity
·
35
Expanding the potential of pyridine scaffold for targeted therapy of cancer: Biological activity, molecular insights, and structure-activity relationship
2024
·
Nimmagadda Venkata Satya Sai Aishwarya
, Gurubasavaraja Swamy Purawarga Matada
, et al.
·
Journal of Molecular Structure
·
24
Advancement of DDR1 and DDR2 Inhibitors: Therapeutic Potential of Bioactive Compounds, Designing Strategies, and Structure‐Activity Relationship (SAR)
2024
·
Rohit Pal
, B. Kumaraswamy
, et al.
·
ChemistrySelect
·
7
Show more works
View as search
Works count:
5
Citation count:
152
H-index:
5
I10-index:
4
Year
Topic
Type
